Gabapentin Treatment of Cannabis Dependence

Completed · Phase 2 · Has a placebo group

Conditions studied: Cannabis Dependence

In brief

This is a study to evaluate the efficacy of the medication gabapentin in treating persons with cannabis dependence.

Key facts

Study ID

NCT00395044

Run by

The Scripps Research Institute

People needed

50

Starts

2006-08-01

Expected to finish

2008-07-01

Last updated by the study team

2017-02-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males or females age 18-65 with cannabis dependence
• Meets DSM-IV-TR criteria for Cannabis Dependence
• Smoked marijuana at least once a week in the 90 days prior to study participation
• Willing to attend 12 weekly study visits and 1 follow-up visit

You may not qualify if…

• Currently meets DSM-IV-TR criteria for dependence on illicit substances other than cannabis
• Significant medical disorders that will increase potential risk or interfere with study participation
• Women with childbearing potential who are pregnant, nursing, or refuse to use a reliable method of birth control
• Treatment with an investigational drug in the last month

Where it is running

• The Scripps Research Institute — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.